By leveraging Cardinal Health’s business and operational expertise and Cordis’ deep experience in product innovation, we are very well positioned to meet the evolving needs of our customers and their patients.
DUBLIN, OHIO, October 9, 2015 — Attendees at the 27th Transcatheter Cardiovascular Therapeutics (TCT) conference, the annual scientific symposium of the Cardiovascular Research Foundation, can experience the launch of Cardinal Health’s expanded portfolio in the cardiovascular space, including the latest innovations from Cordis, a Cardinal Health company.
During the conference, October 11-15, 2015 in San Francisco, attendees will gain insight to the Cardinal Health and Cordis comprehensive offering of high-quality, daily-use products; reliable, trackable inventory and logistics; and deep analytic capabilities. This multi-dimensional set of solutions will become increasingly important with emerging value-based payment models.
“This acquisition brings together two important leaders in the healthcare industry, creating a combined offering in the cardiovascular and medical device space that will ensure greater access to quality products and services worldwide,” said David Wilson, president of Cordis, a Cardinal Health company. “By leveraging Cardinal Health’s business and operational expertise and Cordis’ deep experience in product innovation, we are very well positioned to meet the evolving needs of our customers and their patients.”
Cardinal Health will feature several new technologies and solutions at TCT, including:
Conference attendees can gain insight on the latest advances in current therapies and clinical research from an expert team representing Medstar Washington Hospital Center as they discuss “Exploring Emerging Trends: Managing Large-Bore Complications and Venous Access Site Closure” in a breakfast symposium on Tuesday, Oct. 13 at 7 a.m. in the Moscone Convention Center, room 121.
To learn more about the interventional solutions offered by Cardinal Health and Cordis, visit www.cardinalhealth.com/cardiovascular, or visit booth 1205 at the TCT 2015 conference October 11-15, 2015.
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $103 billion health care services company that improves the cost-effectiveness of health care. Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers, clinical laboratories and physician offices focus on patient care while reducing costs, enhancing efficiency and improving quality. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products and services to more than 100,000 locations each day and is also the industry-leading direct-to-home medical supplies distributor. The company is a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company operates the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Ranked #26 on the Fortune 500, Cardinal Health employs more than 36,000 people worldwide. More information about the company may be found at www.cardinalhealth.com and @CardinalHealth on Twitter.
About Cardiovascular Research Foundation
The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit foundation dedicated to improving the survival and quality of life for people with cardiovascular disease through high quality research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine. Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of CRF, is the world’s premier educational meeting specializing in interventional cardiovascular medicine. For more information, visit www.crf.org and www.tctconference.com.